SCHEMBL6478649

SCHEMBL6478649

C#C[C]C

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Propyne SCHEMBL1330783 0.72
Propyne SCHEMBL2031 0.72
Propyne SCHEMBL9522893 0.72
Propyne SCHEMBL521923 0.72
Propyne SCHEMBL22983240 0.67
Propyne SCHEMBL6886770 0.67
Propyne SCHEMBL7158451 0.67
Propyne SCHEMBL10631146 0.67
Propyne SCHEMBL21797932 0.67
Propyne SCHEMBL20557227 0.67

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 53 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4377311-A1 2-DIAZO-3-OXO-2,3-DIHYDROSPIRO[INDENE-1,9'-XANTHENE] DERIVATIVES AND SIMILAR COMPOUNDS AS PHOTOACTIVE FLUORESCENT COMPOUNDS FOR PROTEIN LABELING Eikon Therapeutics Inc. (US) 2024-06-05 EP disclosed
US-11981703-B2 Polynucleotide constructs SIRIUS THERAPEUTICS, INC. (US) 2024-05-14 US disclosed
US-20230321083-A1 Inhibitors of GPR174 and Uses Thereof OMEROS CORP (US) 2023-10-12 US disclosed
US-20230285556-A1 METHODS AND COMPOSITIONS FOR TREATING CANCER OMEROS CORPORATION 2023-09-14 US disclosed
US-20230242567-A1 CHIRAL PHOSPHORAMIDITE AUXILIARIES AND METHODS OF THEIR USE SIRIUS THERAPEUTICS, INC. 2023-08-03 US disclosed
US-20230181493-A1 BIOMARKERS RELATED TO PARKINSON'S DISEASE AND METHODS OF USING THE SAME SENDA BIOSCIENCES INC (US) 2023-06-15 US disclosed
US-20230086732-A1 PHOTOACTIVE FLUORESCENT COMPOUNDS AND USE THEREOF FOR LABELING OF PROTEINS EIKON THERAPEUTICS INC (US) 2023-03-23 US disclosed
WO-2023039578-A1 METHODS AND COMPOSITIONS FOR TREATING CANCER OMEROS CORPORATION (US) 2023-03-16 WO disclosed
US-11597744-B2 Chiral phosphoramidite auxiliaries and methods of their use SIRIUS THERAPEUTICS, INC. (US) 2023-03-07 US disclosed
WO-2023009503-A1 2-DIAZO-3-OXO-2,3-DIHYDROSPIRO[INDENE-1,9'-XANTHENE] DERIVATIVES AND SIMILAR COMPOUNDS AS PHOTOACTIVE FLUORESCENT COMPOUNDS FOR PROTEIN LABELING EIKON THERAPEUTICS INC. (US) 2023-02-02 WO disclosed
WO-2015069932-A1 POLYNUCLEOTIDE CONSTRUCTS HAVING DISULFIDE GROUPS SOLSTICE BIOLOGICS, LTD. (IE) 2015-05-14 WO disclosed
US-6908884-B2 Benzazolonylcarbonylcyclohexenones and their use as herbicides BASF AKTIENGESELLSCHAFT (DE) 2005-06-21 US disclosed
US-20040224884-A1 Methods of screening for apoptosis-controlling agents for bone anabolic therapies and uses thereof MANOLAGAS STAVROS C (US) 2004-11-11 US disclosed
US-20040063584-A1 Benzazolonylcarbonylcyclohexenones and their use ss herbicides BASF AKTIENGESELLSCHAFT (DE) 2004-04-01 US disclosed
US-20040033899-A1 5[(pyrazol-4-yl)carbonyl]benzazolone as herbicide BASF AKTIENGESELLSCHAFT (DE) 2004-02-19 US disclosed
US-6589915-B1 The invention relates to cyclohexenone derivatives of benzo-condensed, unsaturated 5-ring nitrogen heterocycles of general formula (I) wherein X represents N or a group C-R3, Y represents O, S, SO, SO2 or NR4 or X-Y represent S BASF AKTIENGESELLSCHAFT (DE) 2003-07-08 US disclosed
US-6541423-B1 Controlling vegatation BASF AKTIENGESELLSCHAFT (DE) 2003-04-01 US disclosed
US-6352959-B1 HERBICIDES BASF AKTIENGESELLSCHAFT (DE) 2002-03-05 US disclosed
EP-0332387-B1 Triazole derivatives, their preparation and their use as fungicides SANKYO CO (JP) 1993-11-24 EP disclosed
EP-0332387-A1 Triazole derivatives, their preparation and their use as fungicides Sankyo Company Limited (JP) 1989-09-13 EP disclosed